title: Second response to the letter to the editor referencing the manuscript the "use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial".
authors.forename: L
authors.initials: L
authors.lastname: Kottschade
authors.forename: J
authors.initials: J
authors.lastname: Sloan
authors.forename: C
authors.initials: C
authors.lastname: Loprinzi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000517:prevention & control*; D014810:Vitamin E / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014815:Vitamins; D014810:Vitamin E